Monthly Archives: June 2012

Celecoxib of pr Diktiven markers and accurate predictors Pr For the therapeutic

G218 study, Cohn et al. shown that the addition of bevacizumab for the adjuvant treatment of patients with advanced ovarian cancer is not cost effective and maintenance therapy with bevacizumab, with simultaneous improvement in PFS is connected to both the … Continue reading

Posted in Uncategorized | Leave a comment

AMPA Receptor in clinical trials is the BPR1K653 of the MDR1 gene expression in cancer cells

Cancer cells independent Ngig of their origin and tissue p53 status. AMPA Receptor in clinical trials BPR1K653 is as in inhibiting the growth of multidrug resistance protein expressing cancer cells, it generally shown that the expression of MDR1 in drug-induced … Continue reading

Posted in Uncategorized | Leave a comment

Psychological Stress and Sudden Cardiac Death

Dr. Rachel Lampert presented this lecture as part of the Integrative Medicine Consult Service lecture series sponsored by the National Center for Complementary and Alternative Medicine at the National Institutes of Health. Rachel Lampert, M.D. is an associate professor of … Continue reading

Posted in Uncategorized | Leave a comment

BMS-354825 Dasatinib identified as clearly in our database of mitochondrial processes

ING mitochondrial transcripts and Hom homeostasis Of metal ions. BMS-354825 Dasatinib Because this analysis includes all biological processes and pathways described for the cell, it is striking that the only identified as clearly in our database of mitochondrial processes involved … Continue reading

Posted in Uncategorized | Leave a comment

Preliminary Trial Finds Possible Benefits of Osteopathic Treatment for Back Pain During the Third Trimester of Pregnancy

Most pregnant women experience low-back pain, which often is associated with sleep disturbance and can affect daily activities. Because of possible risks associated with many pain medications, pregnant women and their prenatal care providers often consider using complementary and alternative … Continue reading

Posted in Uncategorized | Leave a comment

In the News: Placebo Effect

Recently, several news outlets have been highlighting research studies of the placebo effect. The placebo response can be defined as the benefit patients receive from a treatment that has no active components. Researchers are using innovative study designs to untangle … Continue reading

Posted in Uncategorized | Leave a comment

LipoTRON Weight Loss Device Under FDA Investigation for Safety and Marketing Issues

by: Jonathan Macri, Esq. Overweight individuals looking for the next easy way to lose weight fast need to be careful or they might get burned…literally. A Fort Worth, Texas company, Advanced Aesthetic Concepts, is under investigation by State Officials looking … Continue reading

Posted in Uncategorized | Leave a comment

Twenty-Sixth NACCAM Meeting, February 2, 2007

The draft agenda is available for the twenty-sixth NACCAM meeting, scheduled for February 2, 2007. NACCAM is charged with the responsibility of advising, consulting with, and making recommendations to the Director, NCCAM, on matters relating to the research activities and … Continue reading

Posted in Uncategorized | Leave a comment

Novacare LLC Conducts Voluntary Nationwide Recall of Products Found to Contain Undeclared Drug Ingredient

Novacare LLC announced today that it is conducting a voluntary nationwide recall of products sold under the following names: Stiff Nights, Aziffa, Size Matters, Erex, Mojo, Hard Drive, Eyeful, Red Magic, Straight Up, Zotrex, Monster Excyte, WOW, Xaitrex, Verect, Prolatis’, … Continue reading

Posted in Uncategorized | Leave a comment

Bitter Orange

This fact sheet provides basic information about bitter orange—common names, uses, potential side effects, and resources for more information. The bitter orange tree is native to eastern Africa and tropical Asia. Today, it is grown throughout the Mediterranean region and … Continue reading

Posted in Uncategorized | Leave a comment